MB-106
Mustang Bio
[]
#17icml: the data presented during an oral presentation at also show 10 out of 20 patients remain in complete remission for more than a year. initial data from ongoing multicenter trial expected shortly. $mbio 
Mustang Bio, a Fortress Biotech company, is focused on the development of novel immunotherapies and gene therapies in areas of unmet need.